Nuveen’s MIRA Pharmaceuticals MIRA Stock Holding History

Nuveen’s Portfolio MIRA Stock Details MIRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$1.9K	Buy	+2,180	New	+$1.79K	﹤0.01%	4862

Other funds holding MIRA

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

CSI

Cross Staff Investments Pittsford, New York $168M AUM 14.41% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $77B AUM 19.24% 1-Year Est. Return

First American Bank Dundee, Illinois $1.81B AUM 24.18% 1-Year Est. Return

IAIM

International Assets Investment Management Orlando, Florida $1.67B AUM 22.25% 1-Year Est. Return

Fifth Third Bancorp Cincinnati, Ohio $61.2B AUM 25.19% 1-Year Est. Return

Caitong International Asset Management Hong Kong $1.04B AUM 150.26% 1-Year Est. Return

Nuveen's MIRA Position: Q3 2026 in Review

Nuveen opened a new position in MIRA Pharmaceuticals (MIRA) in Q3 2026: 2,180 shares worth $1.9K. The stake represents ﹤0.01% of the portfolio and ranks #4862 among its holdings.

8 funds tracked by Wall St. Rank hold MIRA as of Q3 2026.

Nuveen held 2,180 shares of MIRA Pharmaceuticals worth $1.9K as of Q3 2026.
MIRA Pharmaceuticals was a new Nuveen position in Q3 2026.
MIRA Pharmaceuticals made up ﹤0.01% of Nuveen's portfolio in Q3 2026, its #4862 holding.
8 funds tracked by Wall St. Rank held MIRA Pharmaceuticals as of Q3 2026.

Based on Nuveen's 13F filing for Q3 2026, filed 10 Nov 2026.